CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Login
View profile
Log out
Welcome back

Click below to sign in and see leads, RFIs or statistics

Sign in

Sign out
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54
Subscribe

Samchundang Pharm. Co., Ltd

About Samchundang Pharm. Co., Ltd

SamChunDang Pharm. Co., Ltd. is a top Korean pharmaceutical company specializing in ophthalmic products. With US and EU GMP certifications, SCD leads generic ophthalmic production. Our groundbreaking work includes developing a biosimilar for Eylea (Aflibercept), a macular degeneration treatment, with industry recognition. SCD's vision extends beyond ophthalmology, as we're expanding into non-ophthalmic fields like New Drug Delivery System, Oral GLP-1, and Long-acting injections, aiming to revolutionize the global pharmaceutical industry.

Certifications

CE
FDA
GMP
ISO

Sales Markets

Africa
Central America (e.g. Mexico)
East Asia (e.g. China, Japan, Korea)
Europe - EU countries
Europe - non EU (e.g. UK, Russia, ex-CIS countries)
Middle East Region (e.g. UAE)
North America (USA, Canada)
South America (e.g. Brazil, Colombia)
South Asia (e.g. India, Pakistan, Sri Lanka)
South East Asia (e.g. Thailand, Philippines, Singapore)

Categories

Samchundang Pharm. Co., Ltd

KR
2015

On CPHI since
4

Certificates
250 - 499

Employees

Compare

Add to favorites Added to favorites

Company types

Generics/Biosimilars Manufacturer

Primary activities

Pharmaceutical Company (generic finished products)

Contact info

+82 2 2046 1250
Website
71, Jeyakgongdan2-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea, Republic Of

Meet us at

CPHI Milan 2024

Fiera Milano, Italy

08 Oct 2024 - 10 Oct 2024

View Exhibitor Profile